Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cibus Inc (NQ: CBUS )

5.030 +0.430 (+9.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 276,933
Open 4.620
Bid (Size) 4.720 (1)
Ask (Size) 5.400 (18)
Prev. Close 4.600
Today's Range 4.480 - 5.159
52wk Range 4.260 - 23.18
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape
From Cibus US LLC
Via GlobeNewswire
Cibus to Participate in Upcoming August Investor Events
From Cibus US LLC
Via GlobeNewswire

Performance

YTD
-72.60%
-72.60%
1 Month
-31.10%
-31.10%
3 Month
-51.35%
-51.35%
6 Month
-72.19%
-72.19%
1 Year
-70.01%
-70.01%

More News

Read More
CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Cibus Reports Second Quarter Financial Results and Provides First Half Business Update
From Cibus US LLC
Via GlobeNewswire
Cibus Achieves Positive Initial Field Trial Results for Stacked Gene Edited Herbicide Tolerant Traits in Rice
From Cibus US LLC
Via GlobeNewswire
Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits
From Cibus US LLC
Via GlobeNewswire
EXCLUSIVE: Cibus Expands Intellectual Property Coverage For 10 Plant Gene Editing And Trait Families
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development
From Cibus US LLC
Via GlobeNewswire
Cibus Announces $13.0 Million Registered Direct Offering
From Cibus US LLC
Via GlobeNewswire
CIBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cibus, Inc. on Behalf of Cibus Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
Cibus to Participate in Upcoming June Investor Events
From Cibus US LLC
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Cibus, Inc. (CBUS) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
From Cibus US LLC
Via GlobeNewswire
Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding
From Cibus US LLC
Via GlobeNewswire
Cibus to Participate in the BMO Global Farm to Market Conference
From Cibus US LLC
Via GlobeNewswire
CBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Cibus Reports First Quarter Financial Results and Provides Business Update
From Cibus US LLC
Via GlobeNewswire
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
CBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
From Cibus US LLC
Via GlobeNewswire
Earnings Scheduled For March 21, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.